The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies.
Quality in Treatment
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of opioid use disorder (OUD). The objective of this study is to investigate the safety and tolerability of high-dose (>12 mg) buprenorphine induction for patients with OUD presenting to an ED.
Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centres with SBIRT services
Brief treatment (BT) or regular outpatient alcohol use or substance use disorder (SUD) treatment is a key element of the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model. It can be an effective, short-term, and low-cost treatment option for many people who misuse alcohol and drugs. Nevertheless, inconsistent BT implementation often costs similar to regular outpatient care.
Reporting treatment fidelity in behavioral tobacco treatment clinical trials: scoping review and measurement recommendations
Chronic care treatment for smoking cessation in patients with serious mental illness: a pilot randomized trial
Rates of smoking among those with serious mental illness (SMI) are two to three times higher than for the general population. Smoking is rarely addressed in mental health settings. Innovative outreach and treatment strategies are needed to address these disparities.
Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life
Smoking is still prevalent among people with substance use disorders. The objective of this study was to investigate the prevalence of smoking among patients in treatment for substance use disorders and to analyze the effect of smoking both at baseline and follow-up on drop-out, mental health and quality of life.
Effectiveness of a digital alcohol moderation intervention as an add-on to depression treatment for young adults: study protocol of a multicentre pragmatic randomized controlled trial
Depressive disorders and problematic drinking often co-occur, also among young adults. These co-occurring conditions are associated with various negative health outcomes compared to both conditions alone. Early intervention by addressing alcohol use and depressive symptoms simultaneously in the same treatment might improve both conditions.
Collective Voice are delighted to welcome Dame Carol Black as the keynote speaker of our next webinar, presenting the findings from the second part of her Independent Review of Drugs.
Dame Carol's presentation will be followed by comments from Rosanna O'Connor, Interim Director, Health Improvement at Public Health England.
Dame Carol and Rosanna will then take questions.